May 14, 2020
16:00 – 17:00 (CET)
The current health and economic crisis will likely impact corporate VC’s investment strategies. For CVCs in healthcare, the accelerated development, regulatory approval, and adoption of new screening tools, diagnostics, and treatments also creates a wealth of opportunities. In this session, we will hear from experienced investors in this field about their perspectives on the current market dynamics and how these may eventually shape their own investment decisions.